Skip to Content Skip to Content

Medicine

Reset All Filters
1629 Results
Secondary cancers following CAR T cell therapy are rare
3d illustration of a damaged and disintegrating cancer cell.

Image: iStock/vitanovski

Secondary cancers following CAR T cell therapy are rare

A new Penn Medicine analysis shows that the development of any type of second cancer is a rare occurrence, and some of the earliest patients have gone on to experience long-lasting remissions of a decade or more.

From Penn Medicine News

Boy born deaf can hear for the first time thanks to a gene therapy procedure
NBC News

Boy born deaf can hear for the first time thanks to a gene therapy procedure

An experimental gene therapy treatment at the Children’s Hospital of Philadelphia has enabled a deaf 11-year-old boy to be able to hear, with remarks from John A. Germiller of CHOP and the Perelman School of Medicine.

New Penn Medicine Nudge Unit pilots show simple questions can improve care
A patient being wheeled in the hospital flanked by two medical professionals.

Image: iStock/PeopleImages

New Penn Medicine Nudge Unit pilots show simple questions can improve care

Experts at the Penn Medicine Center for Addiction Medicine and Policy have seen success in treatment after posing one question: “Why not treat alcohol use the same way we’ve been treating opioid use?”

Frank Otto

Health systems want tech to make work ‘more human’
Becker’s Hospital Review

Health systems want tech to make work ‘more human’

Penn Medicine CEO Kevin Mahoney says that one of his most exciting challenges in the next year will be integrating technology to streamline care and improve experiences for patients and providers.